
America Great Health
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- $0.008
- Today's High:
- $0.008
- Open Price:
- $0.008
- 52W Low:
- $0.0002
- 52W High:
- $0.09
- Prev. Close:
- $0.0076
- Volume:
- 120000
Company Statistics
- Market Cap.:
- $189.81 million
- Book Value:
- 0
- Revenue TTM:
- $39136
- Operating Margin TTM:
- -7425.18%
- Gross Profit TTM:
- $-1483805
- Profit Margin:
- 0%
- Return on Assets TTM:
- -390.6%
- Return on Equity TTM:
- 0%
Company Profile
America Great Health had its IPO on under the ticker symbol AAGH.
The company operates in the Healthcare sector and Biotechnology industry. America Great Health has a staff strength of 7 employees.
Stock update
Shares of America Great Health opened at $0.01 at the start of the last trading session i.e. 2023-03-24.
The stocks traded within a range of $0.01 - $0.01, and closed at $0.01.
This is a +5.26% increase from the previous day's closing price.
A total volume of 120,000 shares were traded at the close of the day’s session.
In the last one week, shares of America Great Health have slipped by -20.79%.
America Great Health's Key Ratios
America Great Health has a market cap of $189.81 million, indicating a price to book ratio of 358698.7142 and a price to sales ratio of 1491.3564.
In the last 12-months America Great Health’s revenue was $39136 with a gross profit of $-1483805 and an EBITDA of $-4728193. The EBITDA ratio measures America Great Health's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, America Great Health’s operating margin was -7425.18% while its return on assets stood at -390.6% with a return of equity of 0%.
In Q4, America Great Health’s quarterly earnings growth was a positive 0% while revenue growth was a negative 75.4%.
America Great Health’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into America Great Health’s profitability.
America Great Health stock is trading at a EV to sales ratio of 1120.3608 and a EV to EBITDA ratio of -24.7971. Its price to sales ratio in the trailing 12-months stood at 1491.3564.
America Great Health stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $354183.00
- Total Liabilities
- $2.78 million
- Operating Cash Flow
- $-44420.00
- Capital Expenditure
- $44420
- Dividend Payout Ratio
- 0%
America Great Health ended 2023 with $354183.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $354183.00 while shareholder equity stood at $-3963552.00.
America Great Health ended 2023 with $0 in deferred long-term liabilities, $2.78 million in other current liabilities, in common stock, $-8604185.00 in retained earnings and $0 in goodwill. Its cash balance stood at $74572.00 and cash and short-term investments were $74572.00. The company’s total short-term debt was $220,173 while long-term debt stood at $1.13 million.
America Great Health’s total current assets stands at $213688.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $645.00 compared to accounts payable of $1.43 million and inventory worth $121506.00.
In 2023, America Great Health's operating cash flow was $-44420.00 while its capital expenditure stood at $44420.
Comparatively, America Great Health paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $0.01
- 52-Week High
- $0.09
- 52-Week Low
- $0.0002
- Analyst Target Price
- $
America Great Health stock is currently trading at $0.01 per share. It touched a 52-week high of $0.09 and a 52-week low of $0.09. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.01 and 200-day moving average was $0.01 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 1013.7% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About America Great Health
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and the manufacturing and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health was founded in 2013 and is headquartered in Alhambra, California.